Voloridge Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,168
| Closed | -$327K | – | 1150 |
|
|
2025
Q3 | $327K | Sell |
1,168
-10,681
| -90% | -$2.91M | ﹤0.01% | 1122 |
|
|
2025
Q2 | $2.86M | Buy |
11,849
+10,770
| +998% | +$2.55M | 0.01% | 887 |
|
|
2025
Q1 | $263K | Buy |
+1,079
| New | +$325K | ﹤0.01% | 1131 |
|
|
2024
Q4 | – | Sell |
-13,185
| Closed | -$4.41M | – | 1183 |
|
|
2024
Q3 | $4.41M | Sell |
13,185
-20,995
| -61% | -$6.67M | 0.02% | 808 |
|
|
2024
Q2 | $9.33M | Buy |
+34,180
| New | +$9.94M | 0.03% | 579 |
|
|
2024
Q1 | – | Sell |
-9,812
| Closed | -$3.17M | – | 1152 |
|
|
2023
Q4 | $3.17M | Buy |
+9,812
| New | +$3.08M | 0.01% | 719 |
|
|
2023
Q3 | – | Sell |
-22,557
| Closed | -$8.55M | – | 1383 |
|
|
2023
Q2 | $8.55M | Buy |
+22,557
| New | +$9.18M | 0.04% | 506 |
|
|
2023
Q1 | – | Sell |
-57,093
| Closed | -$24M | – | 1370 |
|
|
2022
Q4 | $24M | Buy |
57,093
+25,918
| +83% | +$10.5M | 0.13% | 219 |
|
|
2022
Q3 | $13M | Buy |
31,175
+26,956
| +639% | +$13.4M | 0.07% | 370 |
|
|
2022
Q2 | $2.09M | Sell |
4,219
-18,662
| -82% | -$9.72M | 0.01% | 1002 |
|
|
2022
Q1 | $12.9M | Sell |
22,881
-8,275
| -27% | -$4.99M | 0.07% | 344 |
|
|
2021
Q4 | $23.5M | Sell |
31,156
-90
| -0.3% | -$67.4K | 0.13% | 212 |
|
|
2021
Q3 | $23.3M | Buy |
31,246
+11,707
| +60% | +$8.77M | 0.15% | 168 |
|
|
2021
Q2 | $12.6M | Buy |
19,539
+18,779
| +2,471% | +$11.4M | 0.09% | 321 |
|
|
2021
Q1 | $434K | Sell |
760
-15,903
| -95% | -$9.42M | ﹤0.01% | 1208 |
|
|
2020
Q4 | $9.71M | Sell |
16,663
-25,008
| -60% | -$14.2M | 0.08% | 276 |
|
|
2020
Q3 | $21.5M | Buy |
41,671
+21,799
| +110% | +$11M | 0.18% | 143 |
|
|
2020
Q2 | $8.97M | Buy |
19,872
+18,319
| +1,180% | +$8.08M | 0.1% | 221 |
|
|
2020
Q1 | $544K | Sell |
1,553
-12,674
| -89% | -$4.66M | 0.02% | 686 |
|
|
2019
Q4 | $5.26M | Buy |
+14,227
| New | +$5.02M | 0.1% | 246 |
|
|
2019
Q2 | – | Sell |
-10,065
| Closed | -$3.08M | – | 767 |
|
|
2019
Q1 | $3.08M | Buy |
10,065
+530
| +6% | +$143K | 0.09% | 209 |
|
|
2018
Q4 | $2.21M | Buy |
+9,535
| New | +$2.56M | 0.1% | 188 |
|
|
2018
Q3 | – | Sell |
-19,040
| Closed | -$5.49M | – | 304 |
|
|
2018
Q2 | $5.49M | Sell |
19,040
-2,596
| -12% | -$717K | 0.15% | 149 |
|
|
2018
Q1 | $5.41M | Sell |
21,636
-10,149
| -32% | -$2.58M | 0.13% | 144 |
|
|
2017
Q4 | $7.59M | Buy |
+31,785
| New | +$7.7M | 0.17% | 147 |
|
|
2017
Q3 | – | Sell |
-23,776
| Closed | -$5.38M | – | 390 |
|
|
2017
Q2 | $5.38M | Buy |
23,776
+1,226
| +5% | +$267K | 0.13% | 168 |
|
|
2017
Q1 | $4.5M | Buy |
22,550
+18,162
| +414% | +$3.5M | 0.11% | 216 |
|
|
2016
Q4 | $800K | Buy |
+4,388
| New | +$748K | 0.02% | 512 |
|
Other funds holding BIO
AI
VAM
Voloridge Investment Management's BIO Position: Q4 2025 in Review
Voloridge Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2025, closing a stake of 1,168 shares — an estimated $327K sold.
Voloridge Investment Management first reported a position in BIO in Q4 2016 and held it in 28 quarters. The position peaked at $24M in Q4 2022. 396 funds tracked by Wall St. Rank hold BIO as of Q4 2025.
- Voloridge Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2025 after selling out during the quarter.
- Voloridge Investment Management sold 1,168 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $327K.
- Voloridge Investment Management first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 28 quarters.
- Voloridge Investment Management's Bio-Rad Laboratories Class A position peaked at $24M in Q4 2022.
- 396 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.
Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.